Analytical Solutions from Research to Market

Our scientific expertise, experience across a wide range of therapeutics and regions, multi-continent foundation, and commitment to quality provide complete analytic solutions for protein biologics and cell and gene therapeutics throughout products’ development and regulatory life cycles—from discovery to market.

Group Created with Sketch.
Research
Preclinical
Group 2 Created with Sketch.

Discovery – Pre-clinical

Biologic Candidate Evaluation, Optimization and Selection into IND

Group 3 Created with Sketch.
Phase I
Phase II
Phase III
Group 4 Created with Sketch.

Phase I – Phase III

Release, Clinical Data and Characterization Packages for Accelerating Phase I-III Programs through BLA

Group Created with Sketch.
Registration
Market
Group 2 Created with Sketch.

Registration – Market

Commercial-Stage Comparability Testing by Qualified Advanced Methods

hero-animation

Our Analytical Systems

Enabled by state-of-the-art technology, ProtaGene offers an extensive range of analytical capabilities to support your biotherapeutic or gene & cell therapy projects.

hero-animation

Enhanced Partnerships Offer Strategic Expertise

Perhaps you need support to overcome a specific challenge, or maybe you’re looking for a close partnership throughout your product’s entire life cycle. ProtaGene’s CMC experts are here to help.

Img_MultipleCells_Pattern Created with Sketch.

Subscribe to Our Email List

Consent

Talk to Our Experts

Whether you are looking to learn more about our platforms or get a project started, contact our team today to discover how ProtaGene can support your development programs.

Contact Us